• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Oncogenic role of the Wilms' tumor gene in tumorigenesis of lung cancer

Research Project

Project/Area Number 11670140
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pathological medical chemistry
Research InstitutionOsaka University

Principal Investigator

OJI Yusuke  Osaka University Medical School, Associate Professor, 医学部, 助手 (20294100)

Co-Investigator(Kenkyū-buntansha) SUGIYAMA Haruo  Osaka University Medical School, Professor, 医学部, 教授 (70162906)
SOMA Toshihiro  Osaka University Graduate School of Medicine, Associate Professor, 医学系研究科, 助手 (40273619)
Project Period (FY) 1999 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2000: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 1999: ¥2,500,000 (Direct Cost: ¥2,500,000)
KeywordsWT1 gene / Lung cancer / ウイルムス腫瘍遺伝子 / WT1
Research Abstract

We have previously demonstrated that wild-type Wilms' tumor gene (WT1) is expressed at high levels in both leukemic blast cells and various types of solid tumor cell lines and the growth of these cells was inhibited by the treatment with WT1 antisense oligomers. In the present project, we examined WT1 gene expression in fresh lung cancer tissues and in matched normal lung tissues from 20 patients with lung cancer (14 with adenocaricinoma, 6 with squamous-cell carcinoma) by Real time RT-PCR method. We demonstrated that the WT1 gene was expressed in most of lung cancer tissues examined. The levels of WT1 expression in lung cancer tissues were 10-3000 times higher than that in normal lung tissues. Furthermore, we identified WT1 gene product as a novel tumor antigen of leukemia. These results suggest that oncogenic role of WT1 in tumorigenesis of lung cancer and the possibility that WT1 protein could serve as a target protein for tumor-specific immunity.

Report

(3 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • Research Products

    (15 results)

All Other

All Publications (15 results)

  • [Publications] Oji,Y. et al.: "Expression of the Wilms' tumor gene WT1 solid tumors and its essential role in tumor cell growth."Jpn.J.Cancer Res.. 90. 194-204 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tamaki,H. et al.: "The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes."Leukemia.. 13. 393-399 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tsuboi,A. et al.: "Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyle-colony stimulating factor (G-CSF)."Leuk.Res.. 23. 499-505 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Oka,Y. et al.: "Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' Tumor gene (WT1) product."Immunogenetics.. 51(2). 99-107 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Oji, Y.et al: "Expression of the Wilms' tumor gene WT1 solid tumors and its essential role in tumor cell growth."Jpn.J.Cancer Res.. 90. 194-204 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tamaki, H.et al.: "The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes."Leukemia. 13. 393-399 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tsuboi, A.et al.: "Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)."Leuk.Res.. 23. 499-505 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Oka, Y.et al.: "Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' Tumor gene (WT1) product."Immunogenetics. 51(2). 99-107 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Oji,Y. et al.: "Expression of the Wilms' tumor gene WT1 solid tumors and its essential role in tumor cell growth."Jpn.J.Cancer Res.. 90. 194-204 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Tamaki,H. et al.: "The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes."Leukemia.. 13. 393-399 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Tsuboi,A. et al.: "Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)."Leuk.Res.. 23. 499-505 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Oka,Y. et al.: "Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' Tumor gene (WT1) product."Immunogenetics.. 51(2). 99-107 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Oji Y.et al.: "Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth"Japanese Journal of Cancer Research. 90. 194-204 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Tamaki H.et al.: "The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodyspastic syndromes"Leukemia. 13. 393-399 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Oka Y.et al.: "Cancer immunotherapy targeting Wilms' tumor gene WT1 product"Journal of Immunology. 164. 1873-1880 (2000)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi